Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

2645
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Sanofi to Cut 1,500-2,000 Jobs in France - Report

09/15/2012 | 08:11am US/Eastern

French pharmaceutical giant Sanofi SA (SAN.FR, SNY) will disclose cuts of between 1,500 and 2,000 jobs in France on Sept. 25, French newspaper Le Figaro reported Saturday, without citing sources.

The company plans to reduce its 28,000 payroll in France mainly through attrition, the newspaper said.

In July, Sanofi had said it planned to cut jobs at two French units in a bid to preserve the company's profitability, which has been put at risk by recent patent expirations and the economic recession in most of Europe. The company had said it would detail the job cuts in September.

At the time, French Industry Minister Arnaud Montebourg had criticized the company and said he wouldn't tolerate when profitable companies slash jobs.

A Sanofi spokesman didn't return a phone call seeking comments.

Newspaper Web site: http://www.lefigaro.fr

Write to Inti Landauro at inti.landauro@dowjones.com.

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

React to this article
Latest news on SANOFI
04/16 GENZYME : Patent Issued for Confinement of Kidney Stone Fragments during Lithotr..
04/14 GENZYME : New MS drug shows promise for those with aggressive disease
04/13 SANOFI : Good Morning Sanofi - Monther Shams
04/12 Sarepta Therapeutics Appoints Edward Kaye, M.D., as Interim CEO
04/11 SANOFI : MILITARY $52,461 Federal Contract Awarded to Sanofi Pasteur
04/08 SANOFI : Findings on Dengue Hemorrhagic Fever Reported by Investigators at Sanof..
04/08 GENZYME : "Dosing Regimens for the Treatment of Pompe Disease" in Patent Applica..
04/08 Sarepta Therapeutics Appoints Edward Kaye, M.D., as Interim CEO; Company on T..
04/08 GENZYME : Consortium of LGMD Foundations Expands Free Diagnostic Program with Su..
04/08 GENZYME : Cerdelga® eliglustat Capsules Approved in Japan
Advertisement
Chart
Duration : Period :
Sanofi Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF